Skip to main content

Table 2 Demographics, tumor characteristics, and treatment by CNKSR1 expression status

From: Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer

   CNKSR1 Low (N = 34) % CNKSR1 High (N = 83) % P
Age group       0.72
<64 13 38 36 42  
65+ 21 62 50 58  
Race       0.22
White 23 68 47 55  
Asian/PI 6 18 29 34  
Black or Hispanic 5 15 10 12  
Gender       0.82
Male 17 50 41 48  
Female 17 50 45 52  
Grade       0.04
Well Differentiated (1) 18 53 47 55  
Moderately Diff. (2). 14 41 20 23  
Poorly Diff. (3). 2 6 19 22  
Stage       0.86
Localized 4 12 8 9  
Regional 20 59 49 57  
Distant 10 29 29 34  
TNM (N)       0.70
Lymph Node Negative (N0) 10 29 20 23  
Regional Lymph Nodes (N1) 11 32 34 40  
Unknown (NX) 13 38 32 37  
TNM (M)       0.11
No Metastasis (M0) 21 62 56 65  
Distant Metastasis (M1) 10 29 29 34  
Resection       0.87
Yes 20 59 52 60  
No 14 41 34 40  
Radiation       0.24
Yes 6 18 24 28  
No 28 82 62 72  
Location       0.11
Head 15 44 52 60  
Body/Tail 5 15 15 17  
Unknown 14 41 19 22  
  1. CNKSR1 expression status (low = 0,1; high = 2,3 staining intensity) for pancreatic cancer subjects by demographic, tumor characteristic and treatment option variables